Mingfeng Zhao
机构:Tianjin First Center Hospital, Tianjin Medical University · ORCID:0000-0002-5995-7558
发表论文 253 篇 · 总被引 3324 次 · h-index 30
代表论文
- Latest updates on pathogenesis mechanisms and management strategies for cytokine release syndrome, neurotoxicity, and hemophagocytic lymphohistiocytosis related to CAR-T cell therapies (2025 · Annals of Hematology · 被引 13)
- Multi-granularity enhanced graph convolutional network for aspect sentiment triplet extraction (2025 · Big Data Research · 被引 8)
- Modified CD15/CD16-CLL1 inhibitory CAR-T cells for mitigating granulocytopenia toxicities in the treatment of acute myeloid leukemia (2024 · Translational Oncology · 被引 8)
- Xenopax for the treatment of steroid‑refractory acute graft‑versus‑host disease: the RELAX study (2025 · Military Medical Research · 被引 5)
- Modified Dual CLL1-CD15 and CLL1-CD16 Icar-T Cells for Mitigating Granulocytopenia Toxicities in the Treatment of Acute Myeloid Leukemia (2024 · Blood · 被引 3)
- Split CAR-T Cells Targeting CD312 and TIM-3 for AML to Reduce the Risk of Antigen Escape (2024 · Blood · 被引 2)